fda approved semaglutide approves obesity drug that helped people cut weight 15% FDA has approved a new,
Description
Reimer, R
Compounded semaglutide poses potential risks, and patients and healthcare professionals must be aware of the differences between this medication and its brand name counterparts

Individual susceptibility varies considerably

Early data suggests it provides both substantial weight loss and glucose control (HbA1c reductions)
